Resources

Within3 is Committed to Providing the Most Relevant Information in the Industry

Preparing for Your First Virtual Advisory Board

April 26, 2017 | Blog

When preparing to initiate your first virtual event, whether it be a commercial or medical affairs advisory board, a clinical steering committee or even a patient advocacy session, following standard best practices can greatly increase your business results. 

Read More

How Gov't Health Policy Reforms Impact Pharma

April 20, 2017 | Case Study

The U.S. government is increasingly focused on health care policy reforms, causing pharmaceutical companies to rethink their strategies and tactics in pursuing “share of scripts.” For pharmaceutical companies, these reforms represent a paradigm shift in the structure of the U.S. market, and call for innovative approaches to commercialization and pricing. In a new value-driven health care system, pharmaceutical companies’ drug therapies will need to provide products that demonstrate measurable value to a broader array of stakeholders – physicians, patients, and payers. As a result, companies are faced with an increased need for engaging in discussion across the entire stakeholder ecosystem.

Read More

Clinical Decision Making

April 13, 2017 | White Paper

When optimally managed, the relationship between pharmaceutical organizations and healthcare professionals (HCPs) on the frontlines of patient care is bi-directional. A leading pharmaceutical organization’s joint medical affairs and commercial team, purposed with gaining insight and treatment perspectives about prescribing preferences and informational needs, was tasked with identifying an innovative approach to facilitating bi-directional discussions with leading clinicians around the country. This case study explains how they did it.

Read More

Compliance in Online Discussion Technologies

April 06, 2017 | Article

Pharmaceutical companies are looking for convenient, cost-effective ways to engage physicians, patients, payers, and other external stakeholders throughout the drug development lifecycle. Online discussion technologies have been praised by teams and external stakeholders alike for being efficient and effective.  When first considering online discussion technologies, however, companies often have initial compliance concerns.

Read More

Clinical Trial Decision Making

March 30, 2017 | Case Study

A leading pharmaceutical organization’s medical affairs team facing a go-/no-go clinic trial decision desired to improve their collaboration process – and results. This case study explains how they did it.
Read More